Dorian LPG
LPG
和黃醫藥
HCM
Collegium Pharmaceutical
COLL
4
奧洛茲美醫療
HALO
5
Precision Drilling
PDS
(FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 11.41%6.31億 | 21.51%1.82億 | 16.53%1.59億 | 7.18%1.45億 | 0.11%1.45億 | 22.17%5.67億 | 15.53%1.5億 | 7.63%1.37億 | 9.71%1.36億 | 72.85%1.45億 |
營業收入 | 11.41%6.31億 | 21.51%1.82億 | 16.53%1.59億 | 7.18%1.45億 | 0.11%1.45億 | 22.17%5.67億 | 15.53%1.5億 | 7.63%1.37億 | 9.71%1.36億 | 72.85%1.45億 |
主營業務成本 | 5.61%2.54億 | 51.79%8,366.1萬 | 10.83%6,250.7萬 | -11.75%5,447萬 | -20.63%5,346.7萬 | -5.44%2.41億 | -30.96%5,511.5萬 | -17.27%5,639.8萬 | -13.30%6,172萬 | 91.08%6,736.5萬 |
毛利 | 15.69%3.77億 | 3.87%9,828.8萬 | 20.52%9,679.4萬 | 23.00%9,080.6萬 | 18.16%9,145.6萬 | 55.70%3.26億 | 90.06%9,463萬 | 36.49%8,031.1萬 | 40.99%7,382.6萬 | 59.60%7,740.2萬 |
營業費用 | 32.13%2.1億 | 91.52%6,309.1萬 | 75.52%6,195.5萬 | 13.46%4,333.5萬 | -20.45%4,198.2萬 | -9.63%1.59億 | -13.38%3,294.2萬 | -8.01%3,529.8萬 | -7.42%3,819.3萬 | -9.80%5,277.5萬 |
銷售和管理費用 | 32.13%2.1億 | 91.52%6,309.1萬 | 75.52%6,195.5萬 | 13.46%4,333.5萬 | -20.45%4,198.2萬 | -7.54%1.59億 | -13.38%3,294.2萬 | -8.01%3,529.8萬 | -7.42%3,819.3萬 | -3.21%5,277.5萬 |
研發費用 | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
營業利潤 | 0.01%1.67億 | -42.94%3,519.7萬 | -22.60%3,483.9萬 | 33.22%4,747.1萬 | 100.89%4,947.4萬 | 401.10%1.67億 | 424.69%6,168.8萬 | 119.93%4,501.3萬 | 220.73%3,563.3萬 | 345.90%2,462.7萬 |
淨非營業利息收入(費用) | 11.41%-5,999.8萬 | -39.15%-2,084.2萬 | 6.88%-1,511.4萬 | 37.26%-1,119萬 | 31.20%-1,285.2萬 | -8.94%-6,772.4萬 | 23.38%-1,497.8萬 | 14.74%-1,623萬 | -0.45%-1,783.6萬 | -220.58%-1,868萬 |
利息收入 | -10.50%1,397.6萬 | -57.89%181.2萬 | -27.72%328萬 | 9.19%439.7萬 | 63.34%448.7萬 | 1,391.40%1,561.5萬 | 318.99%430.3萬 | 41,154.55%453.8萬 | 80,440.00%402.7萬 | 68,575.00%274.7萬 |
利息費用 | -11.24%7,397.4萬 | 17.49%2,265.4萬 | -11.43%1,839.4萬 | -28.71%1,558.7萬 | -19.08%1,733.9萬 | 31.84%8,333.9萬 | -6.29%1,928.1萬 | 9.04%2,076.8萬 | 23.10%2,186.3萬 | 267.47%2,142.7萬 |
其他淨收入(費用) | 64.20%-841.5萬 | 291.4萬 | -414.5萬 | -718.4萬 | -2,350.4萬 | 0 | -2,350.4萬 | |||
特殊收入(費用) | 64.20%-841.5萬 | --291.4萬 | ---414.5萬 | ---718.4萬 | --0 | ---2,350.4萬 | --0 | --0 | --0 | ---2,350.4萬 |
-減:重組與併購 | ---291.4萬 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-減:其他特殊費用 | -51.80%1,132.9萬 | --0 | --414.5萬 | --718.4萬 | ---- | --2,350.4萬 | --0 | ---- | ---- | --2,350.4萬 |
稅前利潤 | 30.15%9,856.8萬 | -63.03%1,726.9萬 | -45.87%1,558萬 | 63.49%2,909.7萬 | 308.59%3,662.2萬 | 362.53%7,573.3萬 | 699.54%4,671萬 | 1,909.99%2,878.3萬 | 367.79%1,779.7萬 | -10.83%-1,755.7萬 |
所得稅 | 6.53%2,937.8萬 | -67.96%473.3萬 | -23.36%624.5萬 | 98.14%949.1萬 | 6,900.76%890.9萬 | 817.24%2,757.8萬 | 2,594.93%1,477萬 | 735.79%814.9萬 | 429.21%479萬 | 95.28%-13.1萬 |
除稅後利潤 | 43.68%6,919萬 | -60.75%1,253.6萬 | -54.76%933.5萬 | 50.73%1,960.6萬 | 259.03%2,771.3萬 | 292.60%4,815.5萬 | 543.67%3,194萬 | 4,415.10%2,063.4萬 | 350.57%1,300.7萬 | -33.34%-1,742.6萬 |
持續經營利潤 | 43.68%6,919萬 | -60.75%1,253.6萬 | -54.76%933.5萬 | 50.73%1,960.6萬 | 259.03%2,771.3萬 | 292.60%4,815.5萬 | 543.67%3,194萬 | 4,415.10%2,063.4萬 | 350.57%1,300.7萬 | -33.34%-1,742.6萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 43.68%6,919萬 | -60.75%1,253.6萬 | -54.76%933.5萬 | 50.73%1,960.6萬 | 259.03%2,771.3萬 | 292.60%4,815.5萬 | 543.67%3,194萬 | 4,415.10%2,063.4萬 | 350.57%1,300.7萬 | -33.34%-1,742.6萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 43.68%6,919萬 | -60.75%1,253.6萬 | -54.76%933.5萬 | 50.73%1,960.6萬 | 259.03%2,771.3萬 | 292.60%4,815.5萬 | 543.67%3,194萬 | 4,415.10%2,063.4萬 | 350.57%1,300.7萬 | -33.34%-1,742.6萬 |
基本每股收益 | 49.65%2.14 | -59.38%0.39 | -52.46%0.29 | 57.89%0.6 | 268.63%0.86 | 293.24%1.43 | 557.14%0.96 | 6,000.00%0.61 | 353.33%0.38 | -30.77%-0.51 |
稀釋每股收益 | 44.19%1.86 | -56.63%0.36 | -49.06%0.27 | 52.94%0.52 | 239.22%0.71 | 274.32%1.29 | 495.24%0.83 | 5,200.00%0.53 | 326.67%0.34 | -30.77%-0.51 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- | -- |